ADD/ADHD News

Azstarys had a favorable safety profile, demonstrated efficacy and was well-tolerated compared to other methylphenidate products over 1 year of treatment, according to research presented in the Journal of Child and Adolescent Psychopharmacology.

A Kansas-based biopharmaceutical company has announced positive top-line results from a study assessing the effect of food on absorption of its investigational extended-release tablet therapeutic CTx-1301 to treat ADHD.

Children born to mothers, not fathers, with primary antibody immunodeficiencies had greater risks for certain psychiatric disorders and for suicidal behavior, according to data published in JAMA Psychiatry.

Children born to mothers taking ADHD medication did not have altered neurodevelopment or growth compared with those born to mothers not taking ADHD medication, according to findings published in Molecular Psychiatry.

A digital medicine company has revealed positive topline results of an expansionist study evaluating the efficacy and safety of a novel therapeutic device to treat adolescents with ADHD.

Children exposed to benzodiazepines and/or nonbenzodiazepines, also known as z-hypnotics, prenatally may not have increased risk for ADHD, according to data published in JAMA Network Open.

A multidiagnostic prediction model developed using deep learning was highly predictive of mental disorder diagnosis, according to new data published in JAMA Psychiatry.

A driver training software program reduced the frequency of long glances from the roadway among adolescents with ADHD compared with a control training program, a randomized controlled trial found.

In this video, Pamela Wall, PhD, PMHNP, FAANP, clinical associate professor at the University of New Hampshire Department of Nursing, discussed a presentation she gave at the American Psychiatric Nurses Association Annual Conference.

Children from Brazil exposed to trauma in early childhood are at greater risk for developing psychiatric disorders by their middle childhood years, according to a study published in Lancet Psychiatry.